New therapies for hepatitis C: Latin American perspectives

Publisher： John Wiley & Sons Inc

E-ISSN： 2046-2484|5|1|8-10

ISSN： 2046-2484

Source： CLINICAL LIVER DISEASE (ELECTRONIC), Vol.5, Iss.1, 2015-01, pp. : 8-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The new treatments for hepatitis C virus: An advanced practice provider's perspective

By  

CLINICAL LIVER DISEASE (ELECTRONIC), Vol. 4, Iss. 6, 2014-12 ,pp. : 153-155

John Wiley & Sons Inc

Access to resources Recommend Favorite

What is the ethical responsibility of a provider when prescribing the new direct‐acting antiviral agents to patients with hepatitis C infection?

By  

CLINICAL LIVER DISEASE (ELECTRONIC), Vol. 6, Iss. 5, 2015-11 ,pp. : 117-119

John Wiley & Sons Inc

Access to resources Recommend Favorite

Hepatitis C treatment: Back to the warehouse

By  

CLINICAL LIVER DISEASE (ELECTRONIC), Vol. 6, Iss. 2, 2015-08 ,pp. : 27-29

John Wiley & Sons Inc

Access to resources Recommend Favorite

Hepatitis C treatment in liver transplant setting

By  

CLINICAL LIVER DISEASE (ELECTRONIC), Vol. 5, Iss. 6, 2015-06 ,pp. : 145-149

John Wiley & Sons Inc

Access to resources Recommend Favorite

P2‐Quinazolinones and Bis‐Macrocycles as New Templates for Next‐Generation Hepatitis C Virus NS3/4a Protease Inhibitors: Discovery of MK‐2748 and MK‐6325

By  

CHEMMEDCHEM, Vol. 10, Iss. 4, 2015-04 ,pp. : 727-735

John Wiley & Sons Inc

Access to resources Recommend Favorite